FAiling HearT in the Elderly (FATE) Study
Multicenter, Prospective Observational Study of Patients Aged 65 Years or Older, Hospitalized for Acute Heart Failure.
IRCCS Multimedica
5,000 participants
Nov 19, 2019
OBSERVATIONAL
Conditions
Summary
In 2015 the Italian Ministry of Health invited the Cardiac Research Hospitals of Italy to constitute a Cardiac Network. The aim of the network is to facilitate and promote scientific and technological research in the setting of cardiovascular diseases and related risk factors. The Cardiology Network, responding to the indications of the National Health Research Program, which includes research models oriented towards prevention studies with objectives and priority areas of intervention such as "acquiring scientific knowledge necessary for implementing both secondary and tertiary prevention programs for patients and primary prevention for contacts, where indicated, or for subjects exposed to specific risk factors", aims to identify strategies and/or prognostic and predictive factors of outcomes through the construction of thoroughly studied case series and systematic collection of biological materials, as well as the definition of research models based on clinical outcomes. The Study aims to examine the impact of clinical practice and therapies, analytically considering treatments and other important covariates that contribute in a complex manner to the therapeutic success of patients with heart failure.
Eligibility
Inclusion Criteria3
- Patients aged \> 65 years;
- Patients hospitalized for acute heart failure;
- Signature of informed consent.
Exclusion Criteria3
- Patients with significant valvular pathology at T0/Baseline (index event);
- Patients with malignant neoplasms or systemic pathology with a prognosis "quoad vitam" less than 1 year;
- Patients with known active infectious diseases.
Interventions
The aim is to set up a collection of clinical and instrumental data of usual care from patients hospitalized for acute heart failure aged ≥ 65; at the time of admission and after 6-12 and 18 months from the event (admission).
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06343233